Endothelial cells (EC) derived from embryonic stem cells (ESC) require additional functional characterization before they are used as a cell therapy in order to enhance their potential for engraftment and proliferation. We explore several physiologically relevant functions of ESC-derived EC (ESC-EC), such as its capacity to produce nitric oxide (NO), regulate permeability, activate and express surface molecules for the recruitment of leukocytes in response to inflammatory stimuli, migrate and grow new blood vessels, lay down extracellular matrix, and take up low-density lipoproteins. We also examined the ESC-EC ability to upregulate NO in response to shear stress and downregulate NO in response to pro-inflammatory TNF-α activation. Functional responses of ESC-EC were compared with those of cultured mouse aortic ECs. The ESC-EC exhibit most aspects of functional endothelium, but interesting differences remain. The ESC-EC produced less NO on a per cell basis, but the same amount of NO if quantified based on the area of endothelial tissue. They also exhibit increased angiogenic sprouting and are more resistant to inflammatory signals. We further characterized the subphenotype of our ESC-EC and observed both venous and arterial markers on individual cells with a larger percentage of the cells exhibiting a venous phenotype. These data support the hypothesis that the developmental default pathway is toward a venous EC, and that refinement of methods for differentiation towards arterial EC is required to maintain a homogeneous population.

Keywords:
Embryonic stem cell, Endothelial cell, Endothelial progenitor cell, Vascular progenitor cell, Endothelium, Extracellular matrix, Nitric oxide, Shear stress, Ephrin, Arterial
1.
Li Z, Han Z, Wu JC: Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem 2009;106:194–199.
2.
McCloskey KE, Gilroy ME, Nerem RM: Use of embryonic stem cell-derived endothelial cells as a cell source to generate vessel structures in vitro. Tissue Eng 2005;11:497–505.
3.
McCloskey KE, et al: Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells. Endothelium 2003;10:329–336.
4.
McCloskey KE, et al: Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro. J Vasc Res 2006;43:411–421.
5.
McCloskey KE, Stice SL, Nerem RM: In vitro derivation and expansion of endothelial cells from embryonic stem cells. Methods Mol Biol 2006;330:287–301.
6.
Cines DB, et al: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–3561.
7.
Ballermann BJ, et al: Shear stress and the endothelium. Kidney Int Suppl 1998;67:S100–S108.
8.
Boo YC, et al: Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 2002;277:3388–3396.
9.
Malek AM, Izumo S, Alper SL: Modulation by pathophysiological stimuli of the shear stress-induced up-regulation of endothelial nitric oxide synthase expression in endothelial cells. Neurosurgery 1999;45:334–344, discussion 344–345.
10.
Noris M, et al: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995;76:536–543.
11.
Davis ME, et al: Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 2001;89:1073–1080.
12.
Yoshizumi M, et al: Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993;73:205–209.
13.
mAlbelda SM, et al: Permeability characteristics of cultured endothelial cell monolayers. J Appl Physiol 1988;64:308–322.
14.
Hayashi K, et al: Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept 2004;123:77–83.
15.
Sharkawy AA, et al: Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401–412.
16.
Carmeliet P: Angiogenesis in health and disease. Nat Med 2003;9:653–660.
17.
Risau W: Mechanisms of angiogenesis. Nature 1997;386:671–674.
18.
Asahara T, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–967.
19.
Asahara T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221–228.
20.
Ribatti D, et al: Postnatal vasculogenesis. Mech Dev 2001;100:157–163.
21.
Davis GE, Camarillo CW: Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Exp Cell Res 1995;216:113–123.
22.
Deroanne CF, Lapiere CM, Nusgens BV: In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovasc Res 2001;49:647–658.
23.
Vernon RB, et al: Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Invest 1992;66:536–547.
24.
Conway EM, Collen D, Carmeliet P: Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49:507–521.
25.
Davis GE, Senger DR: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005;97:1093–1107.
26.
Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993;268:26033–26036.
27.
Rhodes JM, Simons M: The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med 2007;11:176–205.
28.
Beck K, Hunter I, Engel J: Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J 1990;4:148–160.
29.
Gospodarowicz D, et al: The production and localization of laminin in cultured vascular and corneal endothelial cells. J Cell Physiol 1981;107:171–183.
30.
Astrof S, Hynes RO: Fibronectins in vascular morphogenesis. Angiogenesis 2009;12:165–175.
31.
Zhou X, et al: Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev 2008;22:1231–1243.
32.
Libby P: Inflammation in atherosclerosis. Nature 2002;420:868–874.
33.
O’Brien KD, et al: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672–682.
34.
Duan H, et al: LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Thromb Haemost 2006;96:807–815.
35.
Werner N, Nickenig G: Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257–266.
36.
Chatzizisis YS, et al: Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379–2393.
37.
Aranguren XL, et al: In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood 2007;109:2634–2642.
38.
Yamashita JK: Differentiation of arterial, venous, and lymphatic endothelial cells from vascular progenitors. Trends Cardiovasc Med 2007;17:59–63.
39.
Red-Horse K, et al: Coronary arteries form by developmental reprogramming of venous cells. Nature 2010;464:549–553.
40.
Dewey CF Jr, et al: The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 1981;103:177–185.
41.
Jo H, Song H, Mowbray A: Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis. Antioxid Redox Signal 2006;8:1609–1619.
42.
Gale NW, et al: Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 2001;230:151–160.
43.
Swift MR, Weinstein BM: Arterial-venous specification during development. Circ Res 2009;104:576–588.
44.
Yosef N, Xia RH, Ubogu EE: Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells. J Neuropathol Exp Neurol 2010;69:82–97.
45.
Kleinman HK, Martin GR: Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005;15:378–386.
46.
Astrof S, Hynes RO: Fibronectins in vascular morphogenesis. Angiogenesis 2009;12:165–175.
47.
Chavakis E, et al: Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 2005;201:63–72.
48.
Hirschi KK, Ingram DA, Yoder MC: Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584–1595.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.